6533b85cfe1ef96bd12bcb99
RESEARCH PRODUCT
STUDY REGARDING THE EVOLUTION OF THE FINANCIAL BALANCE IN THE PHARMACEUTICAL INDUSTRY
Lilia GrigoroiGeorgiana Daniela Minculete (Piko)subject
FinanceliquiditySocial PsychologyHF5001-6182business.industrymedia_common.quotation_subjectEconomics Econometrics and Finance (miscellaneous)Paymentpharmaceutical industryMarket liquidityBalance (accounting)floating assetsnet cashCashEconomicsfloating assets requirementBusiness Management and Accounting (miscellaneous)Businessbusinessmedia_commonPharmaceutical industrydescription
Abstract This article aims at analysing the financial balance within the global pharmaceutical industry, starting from the assumption that „In the pharmaceutical industry there is sufficient liquidity to cover payment obligations”. The analysed companies are part of the exclusive group comprising the top 20 global companies, e.g. GlaxoSmithKline, Merck & Co., Sanofi-Aventis and Bayer. The research conducted is based on an analysis over time of the relationship between floating assets, floating assets requirement and net cash from 2006 to 2013, and highlights the main developments of the indicators before the onset of the financial and economic crisis and after its outbreak.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-12-01 | Revista Economica |